Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912732093> ?p ?o ?g. }
- W2912732093 endingPage "15" @default.
- W2912732093 startingPage "7" @default.
- W2912732093 abstract "The secondary inflammatory injury following intracerebral hemorrhage (ICH) results in increased morbidity and mortality. White blood cells have been implicated as critical mediators of this inflammatory injury. Currently, no medications have been clinically proven to ameliorate or beneficially modulate inflammation, or to improve outcomes by any mechanism, following ICH. However, other neuroinflammatory conditions, such as multiple sclerosis, have approved pharmacologic therapies that modulate the inflammatory response and minimize the damage caused by inflammatory cells. Thus, there is substantial interest in existing therapies for neuroinflammation and their potential applicability to other acute neurological diseases such as ICH. In this review, we examined the mechanism of action of twelve currently approved medications for multiple sclerosis: alemtuzumab, daclizumab, dimethyl fumarate, fingolimod, glatiramer acetate, interferon beta-1a, interferon beta-1b, mitoxantrone, natalizumab, ocrelizumab, rituximab, teriflunomide. We analyzed the existing literature pertaining to the effects of these medications on various leukocytes and also with emphasis on mechanisms of action during the acute period following initiation of therapy. As a result, we provide a valuable summary of the current body of knowledge regarding these therapies and evidence that supports or refutes their likely promise for treating neuroinflammation following ICH." @default.
- W2912732093 created "2019-02-21" @default.
- W2912732093 creator A5002388283 @default.
- W2912732093 creator A5003974931 @default.
- W2912732093 creator A5010061081 @default.
- W2912732093 creator A5045851110 @default.
- W2912732093 creator A5052572280 @default.
- W2912732093 date "2019-01-02" @default.
- W2912732093 modified "2023-10-17" @default.
- W2912732093 title "Modulating acute neuroinflammation in intracerebral hemorrhage: the potential promise of currently approved medications for multiple sclerosis" @default.
- W2912732093 cites W1504018030 @default.
- W2912732093 cites W1537830090 @default.
- W2912732093 cites W1555500764 @default.
- W2912732093 cites W1558860870 @default.
- W2912732093 cites W1965765295 @default.
- W2912732093 cites W1967104669 @default.
- W2912732093 cites W1967496127 @default.
- W2912732093 cites W1967507425 @default.
- W2912732093 cites W1968404112 @default.
- W2912732093 cites W1970288844 @default.
- W2912732093 cites W1972758773 @default.
- W2912732093 cites W1976763103 @default.
- W2912732093 cites W1981621288 @default.
- W2912732093 cites W1981807269 @default.
- W2912732093 cites W1984026653 @default.
- W2912732093 cites W1984555610 @default.
- W2912732093 cites W1985442806 @default.
- W2912732093 cites W1987836619 @default.
- W2912732093 cites W1997220857 @default.
- W2912732093 cites W1998976412 @default.
- W2912732093 cites W2002710238 @default.
- W2912732093 cites W2002967638 @default.
- W2912732093 cites W2004835893 @default.
- W2912732093 cites W2010364287 @default.
- W2912732093 cites W2010958802 @default.
- W2912732093 cites W2011951936 @default.
- W2912732093 cites W2016046171 @default.
- W2912732093 cites W2020047554 @default.
- W2912732093 cites W2020750577 @default.
- W2912732093 cites W2021538155 @default.
- W2912732093 cites W2021724645 @default.
- W2912732093 cites W2024444969 @default.
- W2912732093 cites W2025635957 @default.
- W2912732093 cites W2029207164 @default.
- W2912732093 cites W2031276271 @default.
- W2912732093 cites W2037234036 @default.
- W2912732093 cites W2040568664 @default.
- W2912732093 cites W2042067959 @default.
- W2912732093 cites W2043909825 @default.
- W2912732093 cites W2046128399 @default.
- W2912732093 cites W2046784038 @default.
- W2912732093 cites W2046941822 @default.
- W2912732093 cites W2054226526 @default.
- W2912732093 cites W2054501169 @default.
- W2912732093 cites W2059209526 @default.
- W2912732093 cites W2066219225 @default.
- W2912732093 cites W2069061677 @default.
- W2912732093 cites W2071159407 @default.
- W2912732093 cites W2074888852 @default.
- W2912732093 cites W2076078066 @default.
- W2912732093 cites W2081556209 @default.
- W2912732093 cites W2082618741 @default.
- W2912732093 cites W2087764276 @default.
- W2912732093 cites W2088883527 @default.
- W2912732093 cites W2092246228 @default.
- W2912732093 cites W2093642359 @default.
- W2912732093 cites W2095162130 @default.
- W2912732093 cites W2105167551 @default.
- W2912732093 cites W2108448370 @default.
- W2912732093 cites W2111021842 @default.
- W2912732093 cites W2118695506 @default.
- W2912732093 cites W2121931605 @default.
- W2912732093 cites W2126336004 @default.
- W2912732093 cites W2127685830 @default.
- W2912732093 cites W2130318414 @default.
- W2912732093 cites W2132862382 @default.
- W2912732093 cites W2136325849 @default.
- W2912732093 cites W2140840333 @default.
- W2912732093 cites W2140900977 @default.
- W2912732093 cites W2141111992 @default.
- W2912732093 cites W2149371275 @default.
- W2912732093 cites W2151437297 @default.
- W2912732093 cites W2152236163 @default.
- W2912732093 cites W2154775026 @default.
- W2912732093 cites W2155691943 @default.
- W2912732093 cites W2156239392 @default.
- W2912732093 cites W2161060662 @default.
- W2912732093 cites W2164351607 @default.
- W2912732093 cites W2169082675 @default.
- W2912732093 cites W2171907184 @default.
- W2912732093 cites W2172287266 @default.
- W2912732093 cites W2175101291 @default.
- W2912732093 cites W2177594905 @default.
- W2912732093 cites W2182271449 @default.
- W2912732093 cites W2196906371 @default.
- W2912732093 cites W2328593359 @default.
- W2912732093 cites W2328919898 @default.
- W2912732093 cites W2336862132 @default.